FEZOLINETANT

SynDRA canonical compound SYN0038338 — structure-anchored drug synonym record

Clinical phase	Phase 2
Approval status	Approved · Rx/OTC
Primary target(s)	TACR3
Mechanism of action	neurokinin receptor antagonist

All known targets

veozah
ESN364
ESN-364
AS3472693-00
A2693
Veozah
A-2693
AS-3472693-00
ES-256364
Veoza
((8R)-5,6-DIHYDRO-8-METHYL-3-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)(4-FLUOROPHENYL)METHANONE
(4-FLUOROPHENYL)((8R)-5,6-DIHYDRO-8-METHYL-3-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-(1,2,4)TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)METHANONE
(4-FLUOROPHENYL)((8R)-8-METHYL-3-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-5,6-DIHYDRO-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)METHANONE
(4-fluorophenyl)-[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
(R)-(4-fluorophenyl)(8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone
?ESN-364?
83VNE45KXX
AC-36697
AKOS040741724
BDBM50112244
CHEMBL3608680
compound 3 (PMID:26191358)
compound 3 [PMID:26191358]
CS-7952
D87169
DTXSID601103615
ESN-364ESN-364
EX-A6226
FEZOLINETANT [INN]
Fezolinetant [USAN]
FEZOLINETANT [WHO-DD]
fezolinetantum
GTPL10422
HY-19632
Methanone, ((8R)-5,6-dihydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo(4,3-a)pyrazin-7(8H)-yl)(4-fluorophenyl)-
MS-25636
Q27269455
SCHEMBL16114810